https://www.globenewswire.com/news-release/20...A-SDP.html
CHEYENNE, Wyo., Jan. 21, 2026 (GLOBE NEWSWIRE) -- CS Diagnostics Corp. (OTCQB: CSDX) today detailed its multi-channel sales strategy, global logistics partnerships, and sustainability roadmap supporting the commercial rollout of MEDUSA SDP.
The Company plans to distribute MEDUSA SDP through a diversified sales model designed to serve both institutional and consumer demand.
B2B distribution channels include:
Hospitals and healthcare facilities
Gyms and wellness centers
Schools and educational institutions
Corporate and industrial clients
B2C channels include:
Physical retail Stores shelves, in UAE and Germany.
Online marketplaces such as Amazon, Noon, and leading German e-commerce platforms
Direct-to-consumer sales via the official MEDUSA e-commerce website
To support efficient global fulfillment, DHL has been selected for bulk and institutional shipments, while FedEx will manage retail and consumer-focused deliveries.
Looking ahead, the Company expects to begin regulatory approval processes for a bio-degradable, dissolving MEDUSA SDP wet wipes line, representing a breakthrough advancement in sustainable hygiene solutions and reinforcing CSDX’s long-term environmental strategy.
“CS Group is focused on disciplined execution, strategic partnerships, and scalable growth,” Management stated. “MEDUSA SDP demonstrates how we translate innovation into commercially viable, globally relevant products while advancing sustainability.”